February 18, 2025
What does $2 Billion buy? Click here to explore our new infographic
Fiscal Year 2026 U.S. Investment Case for the Global Fund
Join our Mailing List
Related Posts
Statement on the Global Fund’s landmark agreement to procure long-acting HIV prevention injectable for low- and middle-income countries
Statement on the Global Fund’s landmark agreement to procure long-acting HIV prevention injectable for low- and middle-income countries Chris Collins,...
House Testimony by President & CEO Chris Collins in support of the Global Fund (FY 2026)
Written Testimony submitted by Chris Collins, President and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria,...
Statement on FDA approval of lenacapavir from Chris Collins, President and CEO, Friends of the Global Fight
Statement on FDA approval of lenacapavir from Chris Collins, President and CEO, Friends of the Global Fight “The twice-yearly HIV...